By Sriparna Roy Oct 16 (Reuters) – The European Medicines Agency's committee on Friday recommended approval of Eli Lilly's weight-loss pill Foundayo, the second oral obesity drug to win the agency's
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)